Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mouth Rinses in COVID-19 Patients
NCT04603794Phase 4Unknown
- Sponsor
- The Ohio State University
- Start
- Oct 2020
- Primary completion
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of hydrogen peroxide, chlorhexidine and povidone-iodine in coronavirus disease 2019 (COVID-19) (4 arms), sponsored by The Ohio State University. Primary endpoints: COVID-19 Viral Load by RT-qPCR and Cycle Threshold. Status: unknown.
02
Drugs
hydrogen peroxidechlorhexidinepovidone-iodine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04603794.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04603794.